rs199680125
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_198576.4(AGRN):c.3926G>A(p.Arg1309Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,569,432 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_198576.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGRN | NM_198576.4 | c.3926G>A | p.Arg1309Gln | missense_variant | 23/36 | ENST00000379370.7 | NP_940978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGRN | ENST00000379370.7 | c.3926G>A | p.Arg1309Gln | missense_variant | 23/36 | 1 | NM_198576.4 | ENSP00000368678 | P1 | |
AGRN | ENST00000651234.1 | c.3611G>A | p.Arg1204Gln | missense_variant | 22/38 | ENSP00000499046 | ||||
AGRN | ENST00000652369.1 | c.3611G>A | p.Arg1204Gln | missense_variant | 22/35 | ENSP00000498543 | ||||
AGRN | ENST00000620552.4 | c.3512G>A | p.Arg1171Gln | missense_variant | 23/39 | 5 | ENSP00000484607 |
Frequencies
GnomAD3 genomes AF: 0.00135 AC: 205AN: 151932Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000374 AC: 65AN: 174004Hom.: 0 AF XY: 0.000316 AC XY: 30AN XY: 94884
GnomAD4 exome AF: 0.000126 AC: 178AN: 1417388Hom.: 0 Cov.: 35 AF XY: 0.000108 AC XY: 76AN XY: 702078
GnomAD4 genome AF: 0.00135 AC: 205AN: 152044Hom.: 1 Cov.: 32 AF XY: 0.00132 AC XY: 98AN XY: 74324
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 29, 2020 | See Variant Classification Assertion Criteria. - |
Congenital myasthenic syndrome 8 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at